Latest News about EDIT
Recent news which mentions EDIT
Tickers
EDIT
From Motley Fool
2 Beaten-Down Stocks to Avoid
June 27, 2025
From Motley Fool
From Benzinga
Tickers
EDIT
From Motley Fool
Tickers
EDIT
From Motley Fool
From Benzinga
Earnings Scheduled For May 12, 2025
May 12, 2025
From Benzinga
Earnings Scheduled For March 5, 2025
March 05, 2025
From Benzinga
From Benzinga
Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
December 13, 2024
From Benzinga
This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
December 13, 2024
From Benzinga
Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets Human Proof Of Concept By 2026
December 13, 2024
From Benzinga
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
November 25, 2024
From Benzinga
Expert Outlook: Editas Medicine Through The Eyes Of 7 Analysts
October 23, 2024
Tickers
EDIT
From Benzinga
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
From Motley Fool
From Benzinga
From InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
From InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Tags
EDIT
MRNA
NASDAQ:NTLA,NASDAQ:EDIT,NASDAQ:GNOM,NASDAQ:NTRA,NASDAQ:MRNA,NASDAQ:CRSP,NASDAQ:MYGN,NASDAQ:ILMN
From InvestorPlace
From InvestorPlace
From InvestorPlace
From InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
May 09, 2024
From Motley Fool
Tickers
EDIT
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.